How should I treat?

How should I treat severe paravalvular leakage after TAVI?

EuroIntervention 2013;9:650-653. DOI: 10.4244/EIJV9I5A104

Markus Reinthaler1*, MD; Klaus Empen1, MD; Mathias Busch1, MD; Raik Könemann1, MA; Hüseyin Ince2, MD; Stephan B. Felix1, MD

1. Department of Cardiology, Ernst-Moritz-Arndt University, Greifswald, Germany; 2. Department of Cardiology, University of Rostock, Rostock, Germany

The case presented is of severe paravalvular aortic regurgitation (AR) related to low malpositioning of a 26 mm Medtronic CoreValve (MCV) bioprosthesis performed by a transaortic approach. The prosthesis was sized by two-di

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Share on Facebook Share on Twitter Share on Linkedin

Latest news

NEW ISSUE

EAPCI/ACVC consensus on pVADs, coronary physiology mini focus, a new analysis from the COAPT trial, patient selection for tricuspid interventions and more…

July 20, 2021

Editorial

Treatment of secondary mitral regurgitation in patients with heart failure

Marco Metra et al

July 27, 2021

JAA

This Week's JAA's: Principles and Pitfalls in CFT, Brachial access for PCI....

July 20, 2021

Editorial

Coronary flow capacity: where to next?

Nils P. Johnson

July 20, 2021

Ahead of print

Joint EAPCI/ACVC expert consensus document on pVADs

July 20, 2021

NEW

EuroIntervention's new impact factor!

July 1, 2021

STATE OF THE ART

Completeness of Revascularisation in ACS Patients with Multivessel Disease

Valeria Paradies et al.